Price Capital Management’s ResMed RMD Stock Holding History

Price Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-10,138	Closed	-$728K	–	172
2015 Q1	$728K	Buy	+10,138	New	+$658K	0.45%	40

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Price Capital Management's RMD Position: Q2 2015 in Review

Price Capital Management sold out of ResMed (RMD) in Q2 2015, closing a stake of 10,138 shares — an estimated $728K sold.

Price Capital Management first reported a position in RMD in Q1 2015 and held it in 1 quarter. The position peaked at $728K in Q1 2015. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

Price Capital Management reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
Price Capital Management sold 10,138 ResMed shares in Q2 2015, an estimated $728K.
Price Capital Management first reported a position in ResMed in Q1 2015 and held it in 1 quarter.
Price Capital Management's ResMed position peaked at $728K in Q1 2015.
312 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on Price Capital Management's 13F filing for Q2 2015.